Medtronic Historical Income Statement
MDT Stock | USD 87.15 0.23 0.26% |
Historical analysis of Medtronic PLC income statement accounts such as Gross Profit of 24.8 B can show how well Medtronic PLC performed in making a profits. Evaluating Medtronic PLC income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Medtronic PLC's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Medtronic PLC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medtronic PLC is a good buy for the upcoming year.
Medtronic |
About Medtronic Income Statement Analysis
Medtronic PLC Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Medtronic PLC shareholders. The income statement also shows Medtronic investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Medtronic PLC Income Statement Chart
Medtronic PLC Income Statement is one of the three primary financial statements used for reporting Medtronic's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Medtronic PLC revenue and expense. Medtronic PLC Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Medtronic PLC's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 6.5 B in 2024, whereas Selling General Administrative is likely to drop slightly above 7.5 B in 2024. Add Fundamental
Total Revenue
Total revenue comprises all receipts Medtronic PLC generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Medtronic PLC minus its cost of goods sold. It is profit before Medtronic PLC operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Medtronic PLC. It is also known as Medtronic PLC overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Medtronic PLC operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Medtronic PLC is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Medtronic PLC's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Medtronic PLC current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.At this time, Medtronic PLC's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 6.5 B in 2024, whereas Selling General Administrative is likely to drop slightly above 7.5 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 21.5B | 20.5B | 23.6B | 24.8B | Total Revenue | 31.7B | 31.2B | 35.9B | 37.7B |
Medtronic PLC income statement Correlations
Click cells to compare fundamentals
Medtronic PLC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medtronic PLC income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 3.5B | 3.4B | 3.2B | 3.6B | 4.1B | 4.3B | |
Interest Expense | 1.1B | 925M | 553M | 636M | 731.4M | 768.0M | |
Total Revenue | 28.9B | 30.1B | 31.7B | 31.2B | 35.9B | 37.7B | |
Gross Profit | 19.5B | 19.6B | 21.5B | 20.5B | 23.6B | 24.8B | |
Other Operating Expenses | 23.7B | 25.2B | 25.8B | 25.4B | 29.2B | 30.7B | |
Operating Income | 4.8B | 4.5B | 5.8B | 5.5B | 6.3B | 6.6B | |
Ebit | 4.8B | 4.5B | 5.8B | 5.5B | 6.3B | 3.5B | |
Ebitda | 8.2B | 7.9B | 8.9B | 9.0B | 10.4B | 10.9B | |
Cost Of Revenue | 9.4B | 10.5B | 10.1B | 10.7B | 12.3B | 12.9B | |
Total Operating Expenses | 14.3B | 14.7B | 15.6B | 14.7B | 16.9B | 17.7B | |
Income Before Tax | 4.1B | 3.9B | 5.5B | 5.4B | 6.2B | 6.5B | |
Total Other Income Expense Net | (736M) | (589M) | (235M) | (121M) | (108.9M) | (114.3M) | |
Net Income | 4.8B | 3.6B | 5.0B | 3.8B | 4.3B | 4.5B | |
Income Tax Expense | (751M) | 265M | 456M | 1.6B | 1.8B | 1.9B | |
Research Development | 2.3B | 2.5B | 2.7B | 2.7B | 3.1B | 3.3B | |
Selling General Administrative | 9.9B | 10.1B | 10.3B | 10.4B | 12.0B | 7.5B | |
Net Income Applicable To Common Shares | 4.8B | 3.6B | 5.0B | 3.8B | 4.3B | 3.2B | |
Net Income From Continuing Ops | 4.8B | 3.6B | 5.1B | 3.8B | 4.4B | 4.2B | |
Non Recurring | 313M | 118M | 95M | (30M) | (27M) | (25.7M) | |
Minority Interest | 17M | 174M | (22M) | (26M) | (23.4M) | (22.2M) | |
Tax Provision | (751M) | 265M | 456M | 1.6B | 1.4B | 1.5B | |
Non Operating Income Net Other | 356M | 336M | 318M | 515M | 592.3M | 621.9M | |
Interest Income | 379M | 617M | 541M | 164M | 147.6M | 140.2M | |
Extraordinary Items | (2.3B) | (12M) | 63M | 106M | 121.9M | 128.0M | |
Net Interest Income | (1.1B) | (925M) | (553M) | (636M) | (731.4M) | (768.0M) | |
Reconciled Depreciation | 2.7B | 2.7B | 2.7B | 2.7B | 2.4B | 2.2B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Medtronic Stock analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.078 | Dividend Share 2.75 | Earnings Share 3.15 | Revenue Per Share 24.298 | Quarterly Revenue Growth 0.047 |
The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.